Medical Devices

July 13, 2018

Companies covered: Medtronic, Inc. (NYSE:MDT), Baxter International Inc. (NYSE:BAX), Abbott Laboratories (NYSE:ABT), Tactile Systems Technology, Inc. (NASDAQ:TCMD), DexCom, Inc. (NASDAQ:DXCM), Inogen, Inc (NASDAQ:INGN), Edwards Lifesciences Corporation (NYSE:EW), ABIOMED, Inc. (NASDAQ:ABMD), Intuitive Surgical, Inc. (NASDAQ:ISRG), Amazon.com, Inc. (NASDAQ:AMZN), VolitionRX Limited (NYSEAMERICAN:VNRX), CryoPort Inc. (NASDAQ:CYRX), Gilead Sciences, Inc. (NASDAQ:GILD), Novartis AG (NYSE:NVS), Bristol-Myers Squibb Company (NYSE:BMY), Pfizer, Inc. (NYSE:PFE), Dare Bioscience (NASDAQ:DARE), Merck & Company, Inc. (NYSE:MRK), Biomerica Inc. (NASDAQ:BMRA), Allergan, Inc. (NYSE:AGN), Hologic, Inc. (NASDAQ:HOLX), International Business Machines Corporation (NYSE:IBM), Restoration Robotics, Inc. (NASDAQ:HAIR), Cure Pharmaceutical Holding Corp. (OTCMKTS:CURR), Motus GI Holdings, Inc. (NASDAQ:MOTS), Co-Diagnostics, Inc. (NASDAQ:CODX), electroCore, Inc. (NASDAQ:ECOR), ReWalk Robotics Ltd (NASDAQ:RWLK)

Buy ($175)